Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study
International Journal of Chronic Obstructive Pulmonary Disease · 2024-01 · Volume 19 · 225-241
DOI: 10.2147/copd.s438893 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024-01. Verfasst von Kimberly Daniels und 9 weiteren Autor:innen. Beteiligte Einrichtung: Safety and Epidemiology, Carelon Research, Wilmington, DE, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Cardiovascular Diseases. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: COPD
Abstract (Originalsprache)
Purpose
This study estimated the magnitude and duration of risk of cardiovascular events and mortality following acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and whether risks varied by number and severity of exacerbation in a commercially insured population in the United States.
Methods
This was a retrospective cohort study of newly diagnosed COPD patients ≥40 years old in the Healthcare Integrated Research Database from 2012 to 2019. Patients experiencing exacerbations comprised the "exacerbation cohort". Moderate exacerbations were outpatient visits with contemporaneous antibiotic or glucocorticoid administration; severe exacerbations were emergency department visits or hospitalizations for AECOPD. Follow-up started on the exacerbation date. Distribution of time between diagnosis and first exacerbation was used to assign index dates to the "unexposed" cohort. Cox proportional hazards models estimated risks of a cardiovascular event or death following an exacerbation adjusted for medical and prescription history and stratified by follow-up time, type of cardiovascular event, exacerbation severity, and rank of exacerbation (first, second, or third).
Results
Among 435,925 patients, 170,236 experienced ≥1 exacerbation. Risk of death was increased for 2 years following an exacerbation and was highest during the first 30 days (any exacerbation hazard ratio (HR)=1.79, 95% CI=1.58-2.04; moderate HR=1.22, 95% CI=1.04-1.43; severe HR=5.09, 95% CI=4.30-6.03). Risks of cardiovascular events were increased for 1 year following an AECOPD and highest in the first 30-days (any exacerbation HR=1.34, 95% CI=1.23-1.46; moderate HR=1.23 (95% CI 1.12-1.35); severe HR=1.93 (95% CI=1.67-2.22)). Each subsequent AECOPD was associated with incrementally higher rates of both death and cardiovascular events.
Conclusion
Risk of death and cardiovascular events was greatest in the first 30 days and rose with subsequent exacerbations. Risks were elevated for 1-2 years following moderate and severe exacerbations, highlighting a sustained increased cardiopulmonary risk associated with exacerbations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Safety and Epidemiology, Carelon Research, Wilmington, DE, USA.
- Global Medical Affairs, AstraZeneca, Wilmington, DE, USA.
- College of Medicine, University of Kentucky, Lexington, KY, USA.
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
- BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
ORCID-Profile: Kimberly Daniels, Michael F Pollack
Zitieren
APA
Daniels, K., Lanes, S., Tave, A., Pollack, M. F., Mannino, D. M., Criner, G., Neikirk, A., Rhodes, K., Feigler, N., & Nordon, C. (2024). Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study. International Journal of Chronic Obstructive Pulmonary Disease, Volume 19, 225-241. https://doi.org/10.2147/copd.s438893
Vancouver
Daniels K, Lanes S, Tave A, Pollack MF, Mannino DM, Criner G, et al. Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study. International Journal of Chronic Obstructive Pulmonary Disease. 2024;Volume 19:225-241. doi:10.2147/copd.s438893
BibTeX
@article{Daniels2024,
author = {Daniels, Kimberly and Lanes, Stephan and Tave, Arlene and Pollack, Michael F and Mannino, David M and Criner, Gerard and Neikirk, Amanda and Rhodes, Kirsty and Feigler, Norbert and Nordon, Clementine},
title = {Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2024},
volume = {Volume 19},
pages = {225--241},
doi = {10.2147/copd.s438893}
}
EUVIMED